{"lastClose": 5.960000038146973, "len": 1107, "date": "2023-03-07", "alpha_1": -0.25314241385095637, "beta_1": 1.6349743940818957, "drawup_1": 1.5486725887776869, "natr_1": 14.479091859960535, "sup_1": -0.39653244447474006, "res_1": 0.3260626334670665, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 45.38340925667262, "adx_1": 11.288823791203454, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.022999586148557197, "stratHoldAlpha_1": 250.98381166370103, "stratHoldDrawdown_1": -0.6416778950140261, "alpha_3mo": -0.14260583914249092, "beta_3mo": 1.8886183703905848, "drawup_3mo": 0.4608541290620036, "natr_3mo": 14.479091859960535, "sup_3mo": -0.08948539936898554, "res_3mo": 0.019015668367545768, "bullPattern_3mo": ["DOJI", "HIGHWAVE", "LONGLEGGEDDOJI", "RICKSHAWMAN", "SPINNINGTOP"], "bearPattern_3mo": [], "rsi_3mo": 24.090904263423997, "adx_3mo": 33.83671341453457, "drawdown_3mo": -0.3741647915318814, "stratHoldSharpe_3mo": -2.2476890893644854, "stratHoldAlpha_3mo": 249.64252944798906, "stratHoldDrawdown_3mo": -0.3367483123786933, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "Allogene Therapeutics Inc.", "Market Cap": 850118858, "Sector": "Health Care", "IPO Year": 2018.0, "alpha%_1": 0.2617027961743336, "beta%_1": 0.9040982256242178, "drawup%_1": 0.9971948711844182, "natr%_1": 0.9999967316965546, "drawdown%_1": 0.060846916675304875, "stratHoldSharpe%_1": 0.3907482602880396, "stratHoldAlpha%_1": 0.37121401610393595, "stratHoldDrawdown%_1": 0.047368875151189316, "alpha%_3mo": 0.22003882642602107, "beta%_3mo": 0.950056483473483, "drawup%_3mo": 0.8895347721254051, "natr%_3mo": 0.9999949319547523, "drawdown%_3mo": 0.0028805228918323328, "stratHoldSharpe%_3mo": 0.049857854465415755, "stratHoldAlpha%_3mo": 0.0031946076730495743, "stratHoldDrawdown%_3mo": 0.0035739750713973803}